Rhinophyma is a proliferative condition characterized by hypertrophy of the glandular and porous elements of the nose. Some clinical studies have shown occult basal cell carcinoma in as many as 10% of longterm rhinophyma specimens.
Since this is a proliferative and chronic condition, there is no single treatment that will cure the condition. Rather, treatments will ameliorate the symptoms associated with rhinophyma and provide suitable reduction in size of the nose.
To date, the gold standard for treatment has been the following three modalities:
- Ablative laser
- Chemical peels
- Surgical curettage and dermaplaning
Since Fraxel is relatively expensive and unproven in light of other treatment protocols, the decision should be made to proceed with Fraxel after a thorough discussion of all available options with your surgeon.



Contact the doctor
